Janssen (United Kingdom)

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 10 of 143 papers

  • Open Access
  • Research Article

Randomisation methods in a multi-arm multi-stage platform trial design

  • Mar 11, 2026
  • Research Methods in Medicine & Health Sciences
  • Ruqayya Azher +2
  • Open Access
  • Research Article
  • Citations1

Indirect Treatment Comparisons in EUnetHTA Relative Effectiveness Assessments: Learnings and Recommendations for the Implementation of EU Joint Clinical Assessments.

  • Apr 22, 2025
  • PharmacoEconomics - open
  • Sophie Van Beekhuizen +7
  • Open Access
  • Research Article

Changes in depression medication following the initial assessment by specialised psychiatry services in the Helsinki-Uusimaa Region

  • Apr 01, 2025
  • European Psychiatry
  • J Juntura +9
  • Open Access
  • Research Article
  • Citations5

Health-care resource use and costs associated with inflammatory bowel disease in northwest London: a retrospective linked database study

  • Dec 30, 2024
  • BMC Gastroenterology
  • Zia Ui-Haq +6
  • Open Access
  • Abstract
  • Citations22

Phase 3 Study of Teclistamab (Tec) in Combination with Lenalidomide (Len) and Tec Alone Versus Len Alone in Newly Diagnosed Multiple Myeloma (NDMM) As Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT): Safety Run-in (SRI) Results from the Majestec-4/EMN30 Trial

  • Nov 05, 2024
  • Blood
  • Elena Zamagni +50
  • Open Access
  • PDF
  • Preprint Article

Insights into the use of cytochrome bc1 inhibitors for future therapeutic strategies for tuberculosis

  • Oct 31, 2024
  • Research Square
  • Clara Aguilar Pérez +35
  • Open Access
  • Research Article
  • Citations5

The IL-6 hypothesis in COVID-19: A phase 2, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of free IL-6 sequestration by the monoclonal antibody sirukumab in severe and critical COVID-19

  • Sep 02, 2024
  • Journal of Infection
  • Robert L Gottlieb +17
  • Open Access
  • Research Article
  • Citations1

A hybrid approach to sample size re-estimation in cluster randomized trials with continuous outcomes.

  • Aug 28, 2024
  • Statistics in medicine
  • Samuel K Sarkodie +2
  • Open Access
  • PDF
  • Research Article
  • Citations1

Impact of moderate-to-high-suicide-intent in major depressive disorder: a retrospective cohort study on patient characteristics and healthcare resource utilisation in England

  • Aug 23, 2024
  • BMC Psychiatry
  • Tom Denee +6
  • Open Access
  • Research Article
  • Citations87

Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA

  • Jun 26, 2024
  • Annals of Oncology
  • E Felip +49
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.